DRUG GUIDELINE

Magnesium Sulphate (Non-obstetric)

SCOPE (Area): Emergency, Operating Suite, ICU, General Wards, (Exclude: Paediatrics Seek Advice), Cardiovascular Suite, Coronory Care Unit

SCOPE (Staff): Medical, Nursing, Pharmacy

Printed versions of this document SHOULD NOT be considered up to date / current

Paediatrics (seek Paediatrician advice). For Pre-eclampsia and Eclampsia patients refer to Magnesium Sulfate (Obstetric) Drug Guideline (DRG0036).

See Appendix 1 - Magnesium Sulfate (Non Obstetric) for full version of this Drug Guideline.

	DRG0005 - Calcium Gluconate
	DRG0036 - Magnesium Sulfate (Obstetric)
	CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
	CPG0195 - Intravenous Drug Infusion Preparation Guide For Adults In ICU, ED, Theatre And CVU
	CPP0549 - High Risk Medications
	CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
	DRG0048 - Antibiotic And Electrolyte Maximum Concentrations For Fluid Restricted Icu Patients (Via CVC Only)
	SOP0001 - Principles Of Clinical Care

	Barwon Health (2013, February). Magnesium - General Wards. Barwon Health.
	Barwon Health (2013, February). Magnesium Sulfate- Intensive Care Unit. Barwon Health.
	CRC Press Taylor & Francis Group. (2020). Renal Drug Database. Retrieved September 5, 2020 from
	MIMS Australia. (2020, September). MIMS Online, DBL Magnesium Sulfate Concentrated Injection. Retrieved September 5, 2020, from
	MIMS Australia. (2020, September). MIMS Online, Magnesium Sulfate Injection 50%. Retrieved September 5, 2020, from
	Rossi, S. (2020, July). Australian Medicines Handbook. Retrieved September 5, 2020, from
	The Society of Hospital Pharmacists of Australia (2020, August). Australian Injectable Drugs Handbook (8th ed.). Retrieved September 5, 2020, from
	Therapeutic Guidelines Limited. (2020, August). Therapeutic Guidelines. Retrieved September 5, 2020, from
	Western Health (2009, July). Magnesium Administration. Western Health.
	Wolters Kluwer. (2020) UpToDate. Retrieved September 5, 2020, from

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 01/02/2021
Review Responsibility: Pharmacist - Rotational	Date for Review: 30/11/2025

Magnesium Sulphate (Non-obstetric) - DRG0001 - Version: 7 - (Generated On: 28-05-2025 05:58)